Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts

International Journal of Molecular Medicine

Volumn 32, Issue 4, 2013, Pages 910-916

  Fukuda, Koji ^a   Miura, Yasushi ^a,b   Maeda, Toshihisa ^a   Takahashi, Masayasu ^c   Hayashi, Shinya ^a   Kurosaka, Masahiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c Konan Medical Center   (Japan)

Author keywords

Decoy receptor 3; Fibroblast like synoviocytes; Gene expression profile; Microarray assay; Rheumatoid arthritis

Indexed keywords

COMPLEMENTARY DNA; CYCLOHEXIMIDE; DECOY RECEPTOR 3; RNA; VERY LATE ACTIVATION ANTIGEN 4; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; CASE REPORT; CELL FRACTIONATION; CELL MOTILITY; CELL PROLIFERATION; CYTOSKELETON; DNA MICROARRAY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; ION TRANSPORT; MACROPHAGE; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; RHEUMATOID ARTHRITIS; RNA SYNTHESIS; SYNOVIOCYTE; UPREGULATION;

APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; CLUSTER ANALYSIS; DOWN-REGULATION; FAS LIGAND PROTEIN; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOCLASTS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; RNA; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TRANSCRIPTOME; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84883402883     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1461     Document Type: Article

References (53)

1. Chou CT, Yang JS and Lee MR: Apoptosis in rheumatoid arthritis - expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J Pathol 193: 110-116, 2001.
2. Tak PP, Zvaifler NJ, Green DR and Firestein GS: Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 21: 78-82, 2000.
3. Yamanishi Y, Boyle DL, Rosengren S, Green DR, Zvaifler NJ and Firestein GS: Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 99: 10025-10030, 2002.
4. Hayashi S, Miura Y, Nishiyama T, et al: Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis. Arthritis Rheum 56: 1067-1075, 2007.
5. Pitti RM, Marsters SA, Lawrence DA, et al: Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396: 699-703, 1998.
6. Bai C, Connolly B, Metzker ML, et al: Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci USA 97: 1230-1235, 2000.
7. Ohshima K, Haraoka S, Sugihara M, et al: Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas. Cancer Lett 160: 89-97, 2000.
8. Chen J, Zhang L and Kim S: Quantification and detection of DcR3, a decoy receptor in TNFR family. J Immunol Methods 285: 63-70, 2004.
9. Shi G, Wu Y, Zhang J and Wu J: Death decoy receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo. J Immunol 171: 3407-3414, 2003.
10. Tsuji S, Hosotani R, Yonehara S, et al: Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma. Int J Cancer 106: 17-25, 2003.
11. Yu KY, Kwon B, Ni J, Zhai Y, Ebner R and Kwon BS: A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 274: 13733-13736, 1999.
12. Migone TS, Zhang J, Luo X, et al: TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492, 2002.
13. Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu TL and Lin WW: Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells. Cell Death Differ 11 (Suppl 1): S97-S107, 2004.
14. Hsu MJ, Lin WW, Tsao WC, et al: Enhanced adhesion of monocytes via reverse signaling triggered by decoy receptor 3. Exp Cell Res 292: 241-251, 2004.
15. Tateishi K, Miura Y, Hayashi S, Takahashi M and Kurosaka M: DcR3 protects THP-1 macrophages from apoptosis by increasing integrin alpha4. Biochem Biophys Res Commun 389: 593-598, 2009.
16. Takahashi M, Miura Y, Hayashi S, Tateishi K, Fukuda K and Kurosaka M: DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts. Int J Mol Med 28: 423-427, 2011.
17. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324, 1988.
18. Kamada N, Hisamatsu T, Honda H, et al: TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. Inflamm Bowel Dis 16: 568-575, 2010.
19. Bamias G, Martin C III, Marini M, et al: Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol 171: 4868-4874, 2003.
20. Prehn JL, Mehdizadeh S, Landers CJ, et al: Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin Immunol 112: 66-77, 2004.
21. Papadakis KA, Zhu D, Prehn JL, et al: Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes. J Immunol 174: 4985-4990, 2005.
22. Cassatella MA, Pereira-da-Silva G, Tinazzi I, et al: Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J Immunol 178: 7325-7333, 2007.
23. Prehn JL, Thomas LS, Landers CJ, Yu QT, Michelsen KS and Targan SR: The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. J Immunol 178: 4033-4038, 2007.
24. Zhang J, Wang X, Fahmi H, et al: Role of TL1A in the pathogenesis of rheumatoid arthritis. J Immunol 183: 5350-5357, 2009.
25. Sethi G, Sung B and Aggarwal BB: Therapeutic potential of VEGI/TL1A in autoimmunity and cancer. Adv Exp Med Biol 647: 207-215, 2009.
26. Bamias G, Siakavellas S, Stamatelopoulos K, Chryssochoou E, Papamichael C and Sfikakis P: Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin Immunol 129: 249-255, 2008.
27. Edwards JR, Sun SG, Locklin R, et al: LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. Arthritis Rheum 54: 1451-1462, 2006.
28. Khan J, Simon R, Bittner M, et al: Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 58: 5009-5013, 1998.
29. Espinosa I, Catasus L, Canet B, D'Angelo E, Munoz J and Prat J: Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis. Mod Pathol 24: 846-854, 2011.
30. Chang YC, Chen TC, Lee CT, et al: Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3. Blood 111: 5054-5063, 2008.
31. Li J, Yang S, Lu S, et al: Differential gene expression profile associated with the abnormality of bone marrow mesenchymal stem cells in aplastic anemia. PLoS One 7: e47764, 2012.
32. Whitney LW, Becker KG, Tresser NJ, et al: Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann Neurol 46: 425-428, 1999.
33. Heller RA, Schena M, Chai A, et al: Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 94: 2150-2155, 1997.
34. Lee SK, Jeon EK, Kim YJ, et al: A global gene expression analysis of the peripheral blood mononuclear cells reveals the gene expression signature in psoriasis. Ann Dermatol 21: 237-242, 2009.
35. van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, et al: Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 48: 2132-2145, 2003.
36. Akitaya T and Bronner-Fraser M: Expression of cell adhesion molecules during initiation and cessation of neural crest cell migration. Dev Dyn 194: 12-20, 1992.
37. Kashima T, Nakamura K, Kawaguchi J, et al: Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int J Cancer 104: 147-154, 2003.
38. Marie PJ: Role of N-cadherin in bone formation. J Cell Physiol 190: 297-305, 2002.
39. Nonomura Y, Mizoguchi F, Suzuki A, et al: Hypoxia-induced abrogation of contact-dependent inhibition of rheumatoid arthritis synovial fibroblast proliferation. J Rheumatol 36: 698-705, 2009.
40. Hasko G and Szabo C: IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses. Br J Pharmacol 127: 1295-1304, 1999.
41. Paradowska-Gorycka A, Grzybowska-Kowalczyk A, Wojtecka-Lukasik E and Maslinski S: IL-23 in the pathogenesis of rheumatoid arthritis. Scand J Immunol 71: 134-145, 2010.
42. Swaak AJ, van den Brink HG and Aarden LA: Cytokine production in whole blood cell cultures of patients with rheumatoid arthritis. Ann Rheum Dis 56: 693-695, 1997.
43. Liu FL, Chen CH, Chu SJ, et al: Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway. Rheumatology (Oxford) 46: 1266-1273, 2007.
44. Kim HR, Cho ML, Kim KW, et al: Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways. Rheumatology (Oxford) 46: 57-64, 2007.
45. Kular L, Pakradouni J, Kitabgi P, Laurent M and Martinerie C: The CCN family: a new class of inflammation modulators? Biochimie 93: 377-388, 2011
46. Yadav VK and Ducy P: Lrp5 and bone formation. Ann NY Acad Sci 1192: 103-109, 2010.
47. Gustafsson BI, Thommesen L, Stunes AK, et al: Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 98: 139-151, 2006.
48. Ducy P and Karsenty G: The two faces of serotonin in bone biology. J Cell Biol 191: 7-13, 2010.
49. Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA and Mann M: Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426: 570-574, 2003.
50. Doxsey S, Zimmerman W and Mikule K: Centrosome control of the cell cycle. Trends Cell Biol 15: 303-311, 2005.
51. Shi X, Sun X, Liu M, Li D, Aneja R and Zhou J: CEP70 protein interacts with gamma-tubulin to localize at the centrosome and is critical for mitotic spindle assembly. J Biol Chem 286: 33401-33408, 2011.
52. Shi X, Wang J, Yang Y, Ren Y, Zhou J and Li D: Cep70 promotes microtubule assembly in vitro by increasing microtubule elongation. Acta Biochim Biophys Sin (Shanghai) 44: 450-454, 2012.
53. Leon O and Roth M: Zinc fingers: DNA binding and protein-protein interactions. Biol Res 33: 21-30, 2000.